SHE · Healthcare

Guizhou Bailing Group Pharmaceutical Co Ltd (002424)

Drug Manufacturers - Specialty & Generic

Guizhou Bailing Group Pharmaceutical Co Ltd (002424) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 002424

P/E ratio
18.00

Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — FAQ

What is 002424's P/E ratio?

The price-to-earnings (P/E) ratio for Guizhou Bailing Group Pharmaceutical Co Ltd (002424) is 18.00 (data as of 2026-05-24).

Does Guizhou Bailing Group Pharmaceutical Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Guizhou Bailing Group Pharmaceutical Co Ltd (002424). Check the MyAverix Finance app for the latest dividend data.

What sector is Guizhou Bailing Group Pharmaceutical Co Ltd in?

Guizhou Bailing Group Pharmaceutical Co Ltd (002424) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 002424 listed on?

002424 is listed on SHE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play